Mycobacterium Tuberculosis-IN-2
Mycobacterium Tuberculosis-IN-2 (Compound 29) is a bacterial inhibitor that effectively inhibits Mycobacterium Tuberculosis. Mycobacterium Tuberculosis-IN-2 can be used in tuberculosis research (MIC = 0.07-0.16 μM) [1].
Product Specifications
CAS Number
[2284580-65-8]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mycobacterium-tuberculosis-in-2.html
Solubility
10 mM in DMSO
Smiles
O=S(NCCO)(C1=CC=C(C2=NN(CC3=NC=C(C=C3)F)N=N2)C=C1)=O
Molecular Formula
C15H15FN6O3S
Molecular Weight
378.38
References & Citations
[1]Carlos Alemparte-Gallardo, et al. Novel tetrazole compounds and their use in the treatment of tuberculosis. Patent WO2019034729A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS4380378-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
TNFS15/VEGI (Vascular Endothelial Growth Inhibitor)
Ask
View Details 
MBS4380378-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
TNFS15/VEGI (Vascular Endothelial Growth Inhibitor)
Ask
View Details 
MBS4380378-03 0.1 mg (Without BSA at 1mg/mL)
TNFS15/VEGI (Vascular Endothelial Growth Inhibitor)
Ask
View Details 
MBS4380378-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
TNFS15/VEGI (Vascular Endothelial Growth Inhibitor)
Ask
View Details MBS4380378-05 5x 0.1 mg (Without BSA at 1mg/mL)
TNFS15/VEGI (Vascular Endothelial Growth Inhibitor)
Ask
View Details